CrunchBase is hiring! Check out our open positions →
Register | Login or Login

General Information

Websitechiasmapharma.com
CategoryBioTech
Phone972-2-571-5885
Employees

Offices

Jerusalem, ISR
10 Hartom Street
Jerusalem, 91450, ISR

Funding

TOTAL $90.2M
FUNDING TOTAL $90.2M
Series B, 9/05
Jerusalem Global Ventures
Ofer Hi-Tech
Yissum Research Development
F2 Ventures
$7.7M
Series C, 11/06
MPM Capital
ARCH Venture Partners
Ofer Hi-Tech
F2 Ventures
$44M
Series D, 7/12
Abingworth
MPM Capital
ARCH Venture Partners
$38.5M
DEBT TOTAL $22M
Debt, 3/11
$9M
Debt, 6/11
$10M
Debt, 6/12
$3M

Tags

Chiasma

Chiasma applies its proprietary technology to approved drugs, which not only enables their being switched from injectable to oral, but importantly can result in new indications and/or enhanced absorption. The Company’s Transient Permeability Enhancer technology promotes the delivery of drugs to the GI wall and from there to the liver. It is applicable to macromolecules that to-date can be administered only by injection. TPE can be utilized also with small molecules that are already orally available but are poorly absorbed.

Recent Milestones

  • Dollar
    Chiasma received $38.5M in Series D funding. (7/23/12)
    Posted 7/23/12 at 6:18pm via finsmes.com
  • Dollar
    Chiasma received $3M in Debt funding. (6/8/12)
    Posted 6/8/12 at 5:01am via masshightech.com
  • Check
    Chiasma — reported selling $5.1 million worth of equity and options as part of a planned $23.3 million round (7/1/11)
    Posted 7/5/11 at 5:16am via masshightech.com
  • Dollar
    Chiasma received $10M in Debt funding. (6/15/11)
    Posted 6/15/11 at 6:18pm via masshightech.com
  • Dollar
    Chiasma received $9M in Debt funding. (3/10/11)
    Posted 3/10/11 at 6:42pm via masshightech.com
  • Check
    Chiasma — has added to its debt financing round announced last summer, bumping it up from $2 million to $5 million of a planned $6 million (1/7/11)
    Posted 1/10/11 at 7:03am via masshightech.com
  • Dollar
    Chiasma received $44M in Series C funding. (11/15/06)
    Posted 4/20/10 at 12:06am via allbusiness.com
  • Dollar
    Chiasma received $7.7M in Series B funding. (9/12/05)
    Posted 7/4/10 at 11:52pm

Videos

Screenshots

Chiasma screenshot
Above: Chiasma
Uploaded: 4/20/10

Sources

  1. Cap Funding Report [edit]
  2. Chiasma Raises $44 Million Series C to Fund Clinical Testing, Advance Technology. (allbusiness.com) [edit]
  3. Chiasma caps debt round at a new $9M high (masshightech.com) [edit]
  4. Chiasma keeps the debt round alive, now at $10M (masshightech.com) [edit]
  5. Newton biotech gets $3M in debt financing (masshightech.com) [edit]
  6. Chiasma Closes $38.5M Series D Equity Financing (finsmes.com) [edit]
  7. Chiasma kicks up summer debt round to $5M (masshightech.com) [edit]
    Chiasma closes $5 million of $23 million equity round (masshightech.com) [edit]
Edit This Page
Last Edited 7/23/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy